{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:05:51Z","timestamp":1786982751473,"version":"build-2736575974"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T00:00:00Z","timestamp":1487030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s40256-017-0216-5","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T06:06:51Z","timestamp":1487052411000},"page":"217-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Managing Cardiovascular Risk in Lysosomal Acid Lipase Deficiency"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1727-3510","authenticated-orcid":false,"given":"James J.","family":"Maciejko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,14]]},"reference":[{"key":"216_CR1","volume-title":"The online metabolic and molecular basis of inherited disease","author":"GA Grabowski","year":"2012","unstructured":"Grabowski GA, Du H, Charnas L. Lysosomal acid lipase deficiencies: the Wolman disease\/cholesteryl ester storage disease spectrum. In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, editors. The online metabolic and molecular basis of inherited disease. 8th ed. New York: McGraw-Hill; 2012 (Chapter 142).","edition":"8"},{"key":"216_CR2","first-page":"59","volume":"11","author":"AD Klein","year":"2013","unstructured":"Klein AD. Futerman AH Lysosomal storage disorders: old diseases present and future challenges. Ped Endocrinol Rev. 2013;11:59\u201363.","journal-title":"Ped Endocrinol Rev"},{"key":"216_CR3","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jhep.2013.02.014","volume":"58","author":"DL Bernstein","year":"2013","unstructured":"Bernstein DL, Hulkova H, Bialer MG, Desnick RJ. Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. J Hepatol. 2013;58:1230\u201343.","journal-title":"J Hepatol"},{"key":"216_CR4","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.1016\/S0021-9258(19)40786-2","volume":"250","author":"JL Goldstein","year":"1975","unstructured":"Goldstein JL, Dana SE, Faust JR, Beaudet AL, Brown MS. Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease. J Biol Chem. 1975;250:8487\u201395.","journal-title":"J Biol Chem"},{"key":"216_CR5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","volume":"109","author":"JD Horton","year":"2002","unstructured":"Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109:1125\u201331.","journal-title":"J Clin Invest"},{"key":"216_CR6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/MPG.0000000000000935","volume":"61","author":"BK Burton","year":"2015","unstructured":"Burton BK, Deegan PB, Enns GM, Guardamagna O, Horslen S, Hovingh GK, Lobritto SJ, Malinova V, McLin VA, Raiman J, Di Rocco M, Santra S, Sharma R, Sykut-Cegielska J, Whitley CB, Eckert S, Valayannopoulos V, Quinn AG. Clinical features of lysosomal acid lipase deficiency. J Pediatr Gastroenerol Nutr. 2015;61:619\u201325.","journal-title":"J Pediatr Gastroenerol Nutr."},{"key":"216_CR7","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/ATVBAHA.107.146639","volume":"27","author":"S Muntoni","year":"2007","unstructured":"Muntoni S, Wiebusch H, Jansen-Rust M, Rust S, Seedorf U, Schulte H, Berger K, Funke H, Assman G. Prevalence of cholesteryl ester storage disease. Arterioscler Thromb Vasc Biol. 2007;27:1866\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"216_CR8","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1161\/ATVBAHA.113.302426","volume":"33","author":"NO Stitziel","year":"2013","unstructured":"Stitziel NO, Fouchier SW, Sjouke B, Peloso GM, Moscoso AM, Auer PL, Goel A, Gigante B, Barnes TA, Melander O, Orho-Melander M, Duga S, Sivapalaratnam S, Nikpay M, Martinelli N, Girelli D, Jackson RD, Kooperberg C, Lange LA, Ardissino D, McPherson R, Farrall M, Watkins H, Reilly MP, Rader DJ, de Faire U, Schunkert H, Erdmann J, Samani NJ, Charnas L, Altshuler D, Gabriel S, Kastelein JJP, Defesche JC, Nederveen AJ, Kathiresan S, Hovingh GK. Exome sequencing and directed phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2013;33:2909\u201314.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"216_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","volume":"235","author":"Z Reiner","year":"2014","unstructured":"Reiner Z, Guardamagna O, Nair D, Soran H, Hovingh K, Bertolini S, Jones S, Coric M, Calandra S, Hamilton J, Eagleton T, Ros E. Lysosomal acid lipase deficiency- an under-recognized cause of dyslipidemia and liver dysfunction. Arterioscler. 2014;235:21\u201330.","journal-title":"Arterioscler"},{"key":"216_CR10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/geno.1996.0162","volume":"33","author":"C Aslanidis","year":"1996","unstructured":"Aslanidis C, Reis S, Fehinger P, Buchler C, Klima H, Schmitz G. Genetic and biochemical evidence that CESD and Wolman disease are distinguished by residual lysosomal acid lipase activity. Genomics. 1996;33:85\u201393.","journal-title":"Genomics"},{"issue":"Suppl 3","key":"216_CR11","first-page":"66","volume":"34","author":"D Ameis","year":"1996","unstructured":"Ameis D, Greten H. Lysosomal acid lipase: a pivotal enzyme in the pathogenesis of cholesteryl ester storage disease and Wolman disease. Z Gastroenterol. 1996;34(Suppl 3):66\u20137.","journal-title":"Z Gastroenterol"},{"key":"216_CR12","first-page":"282","volume":"91","author":"A Abramov","year":"1956","unstructured":"Abramov A, Schorr S, Wolman M. Generalized xanthomatosis with calcified adrenals. Amer J Dis Child. 1956;91:282\u20136.","journal-title":"Amer J Dis Child"},{"key":"216_CR13","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1542\/peds.28.5.742","volume":"28","author":"M Wolman","year":"1961","unstructured":"Wolman M, Sterk VV, Gatt S, Frenkel M. Primary familial xanthomatosis with involvement and calcification of the adrenals. Report of two more cases in siblings of a previously described infant. Pediatrics. 1961;28:742\u201357.","journal-title":"Pediatrics"},{"key":"216_CR14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1136\/adc.44.235.331","volume":"44","author":"WC Marshal","year":"1969","unstructured":"Marshal WC, Ockenden BG, Fosbrooke AS, Cumings JN. Wolman\u2019s disease. A rare lipidosis with adrenal calcification. Arch Dis Child. 1969;44:331\u201341.","journal-title":"Arch Dis Child"},{"key":"216_CR15","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1542\/peds.35.4.627","volume":"35","author":"AC Crocker","year":"1965","unstructured":"Crocker AC, Vawter GF, Neuhauser EB, Rosowsky A. Wolman\u2019s disease: three new patients with a recently described lipidosis. Pediatrics. 1965;35:627\u201340.","journal-title":"Pediatrics"},{"key":"216_CR16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00445892","volume":"135","author":"J Schaub","year":"1980","unstructured":"Schaub J, Janka GE, Christmanou H, Sandhoff K, Permanetter W, Hubner G, Meister P. Wolman\u2019s disease: clinical, biochemical and ultrastructural studies in an unusual case without striking adrenal calcification. Eur J Pediatr. 1980;135:45\u201350.","journal-title":"Eur J Pediatr"},{"key":"216_CR17","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0022-2275(20)39119-7","volume":"37","author":"S Ries","year":"1996","unstructured":"Ries S, Aslannidis C, Fehinger P, Carel J-C, Gendrel D, Schmitz G. A new mutation in the gene for lysosomal acid lipase leads to Wolman disease in an African kindred. J Lipid Res. 1996;37:1761\u20135.","journal-title":"J Lipid Res"},{"key":"216_CR18","doi-asserted-by":"crossref","unstructured":"Jones SA, Valayannopoulos V, Schneider E, Eckert S, Bankikazemi M, Bialer M, Cederbaum S, Chan A, Dhawan A, Di Rocco M, Domm J, Enns GM, Finegold D, Gargus JJ, Guardamagna O, Hendriksz C, Mahmoud IG, Raiman J, Selim LA, Whitley CB, Zaki O, Quinn AG. Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants. Genet Med. 2015. www.nature\/gim (advanced online publication).","DOI":"10.1038\/gim.2015.108"},{"key":"216_CR19","doi-asserted-by":"crossref","first-page":"718","DOI":"10.7326\/0003-4819-58-4-718_1","volume":"58","author":"DS Frederickson","year":"1963","unstructured":"Frederickson DS. Newly recognized disorders of cholesterol metabolism. Ann Intern Med. 1963;58:718.","journal-title":"Ann Intern Med"},{"key":"216_CR20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ymgme.2009.02.007","volume":"97","author":"L Pisciotta","year":"2009","unstructured":"Pisciotta L, Fresa R, Bellocchio A, Pino E, Guido V, Cantafora A, Di Rocco M, Calandra S, Bertolini S. Cholesteryl ester storage disease (CESD) due to novel mutations in the LIPA gene. Mol Genet Metab. 2009;97:143\u20138.","journal-title":"Mol Genet Metab"},{"key":"216_CR21","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/01.ATV.15.6.773","volume":"15","author":"U Seedorf","year":"1995","unstructured":"Seedorf U, Wiebusch H, Muntoni S, Christensen NC, Skovby F, Nickel V, Roskos M, Funke H, Ose L, Assman G. A novel variant of lysosomal acid lipase (Leu336->Pro) associated with acid lipase deficiency and cholesterol ester storage disease. Arterioscler Thromb Vasc Biol. 1995;15:773\u20138.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"216_CR22","doi-asserted-by":"crossref","first-page":"27766","DOI":"10.1074\/jbc.270.46.27766","volume":"270","author":"S Sheriff","year":"1995","unstructured":"Sheriff S, Du H, Grabowski GA. Characterization of lysosomal acid lipase by site-directed mutagenesis and heterologous expression. J Biol Chem. 1995;270:27766\u2013277772.","journal-title":"J Biol Chem"},{"key":"216_CR23","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ymgme.2011.11.004","volume":"105","author":"S Saito","year":"2012","unstructured":"Saito S, Ohno K, Suzuki H. Structural bases of Wolman disease and cholesteryl ester storage disease. Mol Genet Metab. 2012;105:244\u20138.","journal-title":"Mol Genet Metab"},{"key":"216_CR24","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1172\/JCI116888","volume":"92","author":"H Klima","year":"1993","unstructured":"Klima H, Ullrich K, Aslanidis C, Fehringer P, Lackner KJ, Schmitz G. A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease. J Clin Invest. 1993;92:2713\u20138.","journal-title":"J Clin Invest"},{"key":"216_CR25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1006\/geno.1994.1180","volume":"20","author":"C Aslanidis","year":"1994","unstructured":"Aslanidis C, Klima H, Lackner KJ, Schmitz G. Genomic organization of human lysosomal acid lipase gene (LIPA). Genomics. 1994;20:329\u201331.","journal-title":"Genomics"},{"key":"216_CR26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF01538859","volume":"7","author":"G Koch","year":"1981","unstructured":"Koch G, Lalley PA, McAvoy M, Shows TB. Assignment of LIPA, associated with human acid lipase deficiency, to human chromosome 10 and comparative assignment to mouse chromosome 19. Somatic Cell Genet. 1981;7:345\u201358.","journal-title":"Somatic Cell Genet"},{"issue":"1","key":"216_CR27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/gm13","volume":"1","author":"PD Stenson","year":"2009","unstructured":"Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NS, Cooper DN. The human gene mutation database: 2008 update. Genome Med. 2009;1(1):13.","journal-title":"Genome Med"},{"key":"216_CR28","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/hep.26327","volume":"58","author":"SA Scott","year":"2013","unstructured":"Scott SA, Liu B, Nazarenko I, Martis S, Kozlitina J, Yao Y, Ramirez C, Kasai Y, Hyatt T, Inga P, Desnick RJ. Frequency of the cholesteryl ester storage disease common LIPA E8SJM mutation (c.894G>A) in various racial and ethnic groups. Hepatology. 2013;58:958\u201365.","journal-title":"Hepatology"},{"key":"216_CR29","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0022-2275(20)32518-9","volume":"39","author":"F Pagani","year":"1998","unstructured":"Pagani F, Pariyarath R, Garcia R, Stuani C, Burlina AB, Ruotolo G, Rabusin M, Baralle FE. New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease. J Lipid Res. 1998;39:1382\u20138.","journal-title":"J Lipid Res"},{"key":"216_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0022-2275(20)39900-4","volume":"36","author":"D Ameis","year":"1995","unstructured":"Ameis D, Brockman G, Knoblich R, Merkal M, Ostlund RE, Yang JW, Coates PM, Cortner JA, Feinman SV, Greten H. A 5\u2032 splice-region mutation and a dinucleotide deletion in the lysosomal acid lipase gene in two patients with cholesteryl ester storage disease. J Lipid Res. 1995;36:241\u201350.","journal-title":"J Lipid Res"},{"key":"216_CR31","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0022-2275(20)32070-8","volume":"41","author":"P Lohse","year":"2000","unstructured":"Lohse P, Maas S, Lohse P, Elleder M, Kirk JM, Besley GT, Seidel D. Compound heterozygosity for a Wolman mutation is frequent among patients with cholesteryl ester storage disease. J Lipid Res. 2000;41:23\u201331.","journal-title":"J Lipid Res"},{"key":"216_CR32","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1194\/jlr.M800027-JLR200","volume":"49","author":"AS Peterson","year":"2008","unstructured":"Peterson AS, Fong LG, Young SG. PCSK9 function and physiology. J Lipid Res. 2008;49:1303\u201311.","journal-title":"J Lipid Res"},{"key":"216_CR33","doi-asserted-by":"crossref","first-page":"30624","DOI":"10.1074\/jbc.M111.274381","volume":"286","author":"KL Bowden","year":"2011","unstructured":"Bowden KL, Bilbey NJ, Bilawchuk LM, Boadu E, Sidhu R, Ory DS, Du H, Chan T, Francis GA. Lysosomal acid lipase deficiency impairs regulation of ABCA1 gene and formation of high density lipoproteins in cholesteryl ester storage disease. J Biol Chem. 2011;286:30624\u201335.","journal-title":"J Biol Chem"},{"key":"216_CR34","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1073\/pnas.72.8.2925","volume":"72","author":"MS Brown","year":"1975","unstructured":"Brown MS, Dana SE, Goldstein JL. Receptor-dependent hydrolysis of cholesteryl esters contained in plasma low density lipoprotein. Proc Natl Acad Sci USA. 1975;72:2925\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"216_CR35","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1172\/JCI113259","volume":"80","author":"HN Ginsberg","year":"1987","unstructured":"Ginsberg HN, Le NA, Short MP, Ramakrishnan R, Desnick RJ. Suppression of apolipoprotein B production during treatment of cholesteryl ester storage disease with lovastatin. Implications for regulation of apolipoprotein B synthesis. J Clin Invest. 1987;80:1692\u20137.","journal-title":"J Clin Invest"},{"key":"216_CR36","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/clinchem\/41.1.111","volume":"41","author":"MH Cummings","year":"1995","unstructured":"Cummings MH, Watts GF. Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in cholesteryl ester storage disease. Clin Chem. 1995;41:111\u20134.","journal-title":"Clin Chem"},{"key":"216_CR37","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/j.1365-2559.2011.04164.x","volume":"60","author":"H Hulkova","year":"2012","unstructured":"Hulkova H, Elleder M. Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimens. Histopath. 2012;60:1107\u201313.","journal-title":"Histopath"},{"key":"216_CR38","doi-asserted-by":"crossref","first-page":"e20160214","DOI":"10.1542\/peds.2016-0214","volume":"138","author":"RW Himes","year":"2016","unstructured":"Himes RW, Barlow SE, Bove K, Quintanilla NM, Sheridan R, Kohli R. Lysosomal acid lipase deficiency unmasked in two children with nonalcoholic fatty liver disease. Pediatrics. 2016;138:e20160214.","journal-title":"Pediatrics"},{"key":"216_CR39","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jpeds.2011.01.038","volume":"159","author":"O Guardamagna","year":"2011","unstructured":"Guardamagna O, Abello O, Anfossi G, Pirro M. Lipoprotein (a) and family history of cardiovascular disease in children with familial dyslipidemias. J Pediatr. 2011;159:314\u20139.","journal-title":"J Pediatr"},{"key":"216_CR40","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0168-8278(99)80356-0","volume":"31","author":"S Dahl von","year":"1999","unstructured":"von Dahl S, Harzer K, Rolfs A, Albrecht B, Niederau C, Vogt C, van Weely S, Aerts J, Muller G, Haussinger D. Heptospenomegaliclipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase -1 exon 8 splice junction mutation. J Hepatol. 1999;31:741\u20136.","journal-title":"J Hepatol"},{"key":"216_CR41","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0168-8278(97)80092-X","volume":"27","author":"C Gasche","year":"1997","unstructured":"Gasche C, Aslanidis C, Kain R, Exner M, Helbich T, Dejaco C, Schmitz G, Ferenci P. A novel variant of lysosomal acid lipase in cholesteryl ester storage disease associated with mild phenotype and improvement on lovastatin. J Hepatol. 1997;27:744\u201350.","journal-title":"J Hepatol"},{"key":"216_CR42","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/BF01605297","volume":"416","author":"M Elleder","year":"1990","unstructured":"Elleder M, Ledvinova J, Cieslar P, Kuhn R. Subclinical course of cholesterol ester storage disease (CESD) diagnosed in adulthood. Virchows Archiv A Pathol Anat. 1990;416:357\u201365.","journal-title":"Virchows Archiv A Pathol Anat"},{"key":"216_CR43","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/ajmg.1320240416","volume":"24","author":"PT Cagle","year":"1986","unstructured":"Cagle PT, Ferry GD, Beaudet AL, Hawkins EP. Pulmonary hypertension in an 18-year old girl with cholesteryl ester storage disease (CESD). Am J Med Genet. 1986;24:711\u201322.","journal-title":"Am J Med Genet"},{"key":"216_CR44","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1172\/JCI106997","volume":"51","author":"HR Sloan","year":"1972","unstructured":"Sloan HR, Frederickson DS. Enzyme deficiency in cholesteryl ester storage disease. J Clin Invest. 1972;51:1923\u20136.","journal-title":"J Clin Invest"},{"key":"216_CR45","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0022-3476(77)80557-X","volume":"90","author":"AL Beaudet","year":"1977","unstructured":"Beaudet AL, Ferry GD, Nichols BL, Rosenberg HS. Cholesteryl ester storage disease: clinical, biochemical and pathological studies. J Pediatr. 1977;90:910\u20134.","journal-title":"J Pediatr"},{"key":"216_CR46","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/MPG.0b013e31819f659b","volume":"50","author":"W Haller","year":"2010","unstructured":"Haller W, Sharif K, Millar AJW, Brown RM, McKiernan PJ. Gallbladder dysfunction in cholesterol ester storage disease. J Pediatr Gastroenterol Nutr. 2010;50:555\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"216_CR47","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/MPG.0b013e31828b36ac","volume":"56","author":"B Zhang","year":"2013","unstructured":"Zhang B, Porto AF. Cholesteryl ester storage disease: protean presentations of lysosomal acid lipase deficiency. J Pediatr Gastroenterol Nutr. 2013;56:682\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"216_CR48","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1194\/jlr.R800091-JLR200","volume":"50","author":"JD Horton","year":"2009","unstructured":"Horton JD, Cohen JC, Hobbs HH. PCSK9: a convertase that coordinates LDL catabolism. J Lipid Res. 2009;50:S172\u20137.","journal-title":"J Lipid Res"},{"key":"216_CR49","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s10620-008-0310-2","volume":"54","author":"H Chatrath","year":"2009","unstructured":"Chatrath H, Keilin S, Attar BM. Cholesterol ester storage disease (CESD) diagnosed in an asymptomatic adult. Dig Dis Sci. 2009;54:168\u201373.","journal-title":"Dig Dis Sci"},{"key":"216_CR50","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ncpcardio0836","volume":"4","author":"AK Soutar","year":"2007","unstructured":"Soutar AK, Naoumova RP. Mechanisms of disease: genetic causes of familial hypercholesterolemia. Nat Clin Pract Cardiovasc Med. 2007;4:214\u201325.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"216_CR51","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2015.08.002","volume":"10","author":"HE Bays","year":"2016","unstructured":"Bays HE, Jones PH, Orringer CE, Brown WV, Jacobson TA. National lipid association annual summary of clinical lipidology. J Clin Lipidol. 2016;10:S1\u201343.","journal-title":"J Clin Lipidol"},{"key":"216_CR52","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"BG Nordestgaard","year":"2013","unstructured":"Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Boren J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AF, Stroes E, Taskinen MR, Tybjaerg-Hansen A, European Atherosclerosis Society Consensus Panel. Familial hypercholesterolemia is underdiagnosed and untreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. Eur Heart J. 2013;34:3478\u201390.","journal-title":"Eur Heart J"},{"key":"216_CR53","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1161\/hq0202.104059","volume":"22","author":"MJ Veerkamp","year":"2002","unstructured":"Veerkamp MJ, de Graaf J, Bredie SJH, Hendricks JCM, Demacker PNM, Stalenhoef AFH. Diagnosis of familial combined hyperlipidemia based on lipid phenotype express in 32 families. Results of a 5-year follow-up study. Arterioscler Thromb Vasc Biol. 2002;22:274\u201382.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"216_CR54","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","volume":"342","author":"DS Pratt","year":"2000","unstructured":"Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. NEJM. 2000;342:1266\u201371.","journal-title":"NEJM"},{"key":"216_CR55","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cca.2012.03.019","volume":"413","author":"J Hamilton","year":"2012","unstructured":"Hamilton J, Jones J, Srivastava R, Galloway P. A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2. Clin Chem Acta. 2012;413:1207\u201310.","journal-title":"Clin Chem Acta"},{"key":"216_CR56","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1381-1177(03)00052-3","volume":"22","author":"M Mukherjee","year":"2003","unstructured":"Mukherjee M. Human digestive and metabolic lipases-a brief review. J Mol Catal B Enzym. 2003;22:369\u201376.","journal-title":"J Mol Catal B Enzym"},{"key":"216_CR57","doi-asserted-by":"crossref","first-page":"5281","DOI":"10.1021\/jm100499s","volume":"53","author":"AJ Rosenbaum","year":"2010","unstructured":"Rosenbaum AJ, Cosner CC, Mariani CJ, Maxfield FR, Wiest O, Helquist P. Thiadiazole carbamates: potent inhibitors of lysosomal acid lipase and potential Niemann\u2013Pick type C therapeutics. J Med Chem. 2010;53:5281\u20139.","journal-title":"J Med Chem"},{"key":"216_CR58","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1501365","volume":"373","author":"BK Burton","year":"2015","unstructured":"Burton BK, Balwani F, Feillet F, Baric TA, Burrow C, Camarena Grande C, Coker M, Consuelo-Sanchez A, Deegan P, DiRicco M, Enns GM, Erbe R, Ezgu F, Ficicioglu C, Furuya KN, Kane J, Laukaitis C, Mengel E, Neilan EG, Nightengale S, Peters H, Scarpa M, Schwab KO, Smolka V, Valayannopoulos V, Wood M, Goodman Z, Yang Y, Eckert S, Rojas-Caro S, Quinn AG. A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency. New Engl J Med. 2015;373:1010\u201320.","journal-title":"New Engl J Med"},{"key":"216_CR59","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOL.0b013e328361f6c6","volume":"24","author":"SW Fouchier","year":"2013","unstructured":"Fouchier SW, Defesche JC. Lysosomal acid lipase A and the hypercholesterolaemic phenotype. Curr Opin Lipidol. 2013;24:332\u20138.","journal-title":"Curr Opin Lipidol"},{"key":"216_CR60","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","volume":"385","author":"J Fulcher","year":"2015","unstructured":"Cholesterol Treatment Trialists\u2019 (CTT) Collaboration, Fulcher J, O\u2019Connell R, Voysey M, Emberson J, Blackwell L, Mihaylova B, Simes J, Collins R, Kirby A, Colhoun H, Braunwald E, LaRosa J, Pedersen TR, Tonkin A, Davis B, Sleight P, Franzosi MG, Baigent C, Keech A. Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomized trials. Lancet. 2015;385:1397\u2013405.","journal-title":"Lancet"},{"key":"216_CR61","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrcardio.2013.80","volume":"10","author":"Z Reiner","year":"2013","unstructured":"Reiner Z. Statins in the primary prevention of cardiovascular disease. Nat Rev Cardiol. 2013;10:453\u201364.","journal-title":"Nat Rev Cardiol"},{"key":"216_CR62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-511X-4-26","volume":"4","author":"VT Tadiboyina","year":"2005","unstructured":"Tadiboyina VT, Liu DM, Miskie BA, Wang J, Hegele RA. Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage disease. Lipids Health Dis. 2005;4:1\u20136.","journal-title":"Lipids Health Dis"},{"key":"216_CR63","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-2275(20)41416-6","volume":"33","author":"R Levy","year":"1992","unstructured":"Levy R, Ostlund RE, Schonfeld G, Wong P, Semenkovich CF. Cholesteryl ester storage disease: complex molecular effects of chronic lovastatin therapy. J Lipid Res. 1992;33:1005\u201315.","journal-title":"J Lipid Res"},{"key":"216_CR64","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJMe1509055","volume":"373","author":"DJ Rader","year":"2015","unstructured":"Rader DJ. Lysosomal acid lipase deficiency-a new therapy for a genetic lipid disease. New Engl J Med. 2015;373:1071\u20133.","journal-title":"New Engl J Med"},{"key":"216_CR65","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0022-3476(05)81866-9","volume":"118","author":"MD Tarantino","year":"1991","unstructured":"Tarantino MD, McNamara DJ, Granstrom P, Ellefson RD, Unger EC, Udall JN. Lovastatin therapy for cholesterol ester storage disease in two sisters. J Pediatr. 1991;118:131\u20135.","journal-title":"J Pediatr"},{"key":"216_CR66","doi-asserted-by":"crossref","first-page":"199","DOI":"10.5414\/CPP39199","volume":"39","author":"F Rassoul","year":"2001","unstructured":"Rassoul F, Richter V, Lohse P, Naumann A, Purschwitz K, Keller E. Long-term administration of the HMG CoA reductase inhibitor lovastatin in two patients with cholesteryl ester storage disease. J Clin Pharmacol Therap. 2001;39:199\u2013204.","journal-title":"J Clin Pharmacol Therap"},{"key":"216_CR67","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0022-3476(05)83074-4","volume":"119","author":"L Leone","year":"1991","unstructured":"Leone L, Ippoliti PF. Use of simvastatin plus cholestyramine in the treatment of lysosomal acid lipase deficiency. J Pediatr. 1991;119:1008\u20139.","journal-title":"J Pediatr"},{"key":"216_CR68","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0022-3476(95)70103-6","volume":"127","author":"L Leone","year":"1995","unstructured":"Leone L, Ippoliti PF, Antonicelli R, Balli F, Gridelli B. Treatment and liver transplantation for cholesterol ester storage disease. J Pediatr. 1995;127:509.","journal-title":"J Pediatr"},{"key":"216_CR69","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/hep.1840110509","volume":"11","author":"AM Bisceglie","year":"1990","unstructured":"Bisceglie AM, Ishak KG, Rabin L, Hoeg JM. Cholesteryl ester storage disease: hepatopathology and effects of therapy with lovastatin. Hepatol. 1990;11:764\u201372.","journal-title":"Hepatol"},{"key":"216_CR70","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bmt.1702557","volume":"26","author":"W Krivit","year":"2000","unstructured":"Krivit W, Peters C, Dusenbery K, Ben-Yoseph Y, Ramsey NK, Wagner JE, Andersen R. Wolman disease successfully treated by bone marrow transplantation. Bone Marrow Transplant. 2000;26:567\u201370.","journal-title":"Bone Marrow Transplant"},{"key":"216_CR71","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00431-006-0298-6","volume":"166","author":"J Stein","year":"2007","unstructured":"Stein J, Gary BZ, Dror Y, Fenig E, Zeigler M, Yaniv I. Successful treatment of Wolman disease by unrelated umbilical cord blood transplantation. Eur J Pediatr. 2007;166:663\u20136.","journal-title":"Eur J Pediatr"},{"key":"216_CR72","first-page":"810","volume":"80","author":"EC Kyriakides","year":"1972","unstructured":"Kyriakides EC, Paul B, Baliant JA. Lipid accumulation and acid lipase deficiency in fibroblasts from a family with Wolman\u2019s disease, and their apparent correction in vitro. J Lab Clin Med. 1972;80:810\u20136.","journal-title":"J Lab Clin Med"},{"key":"216_CR73","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0021-9258(17)33434-8","volume":"251","author":"MS Brown","year":"1976","unstructured":"Brown MS, Sobhani MK, Brunschede GY, Goldstein JL. Restoration of a regulatory response to low density lipoprotein in acid lipase-deficient human fibroblasts. J Biol Chem. 1976;251:3277\u201386.","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"216_CR74","first-page":"97","volume":"10","author":"W Krivit","year":"1992","unstructured":"Krivit W, Freese D, Chan KW, Kulkarni R. Wolman\u2019s disease: a review of treatment with bone marrow transplantation and considerations for the future. Bone Marrow Transplant. 1992;10(Suppl 1):97\u2013101.","journal-title":"Bone Marrow Transplant"},{"key":"216_CR75","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/bmt.2008.273","volume":"43","author":"J Tolar","year":"2009","unstructured":"Tolar J, Petryk A, Khan K, Bjoraker KJ, Jessurum J, Dolan M, Kivisto T, Charnas L, Shapiro EG, Orchard PJ. Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease. Bone Marrow Transplant. 2009;43:21\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"216_CR76","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1097\/00004836-199108000-00028","volume":"13","author":"JN Arterburn","year":"1991","unstructured":"Arterburn JN, Lee WM, Wood RP, Shaw BW, Markin RS. Orthoptic liver transplantation for cholesterl ester storage disease. J Clin Gastroenterol. 1991;13:482\u20135.","journal-title":"J Clin Gastroenterol"},{"key":"216_CR77","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00005176-199104000-00016","volume":"12","author":"GD Ferry","year":"1991","unstructured":"Ferry GD, Whisennand HH, Finegold MJ, Alpert E, Glombicki A. Liver transplantation for cholesteryl ester storage disease. J Pediatr Gastroenterol Nutr. 1991;12:376\u20138.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"216_CR78","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00005176-199501000-00016","volume":"20","author":"AS Kale","year":"1995","unstructured":"Kale AS, Ferry GD, Hawkins EP. End-stage renal disease in a patient with cholesteryl ester storage disease following successful liver transplantation and cyclosporine immunosuppression. J Pediatr Gastroenterol Nutr. 1995;20:95\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"216_CR79","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/hmg\/7.9.1347","volume":"7","author":"H Du","year":"1998","unstructured":"Du H, Duanmu M, Witte D, Grabowski GA. Targeted disruption of the mouse lysosomal acid lipase gene: long-term survival with massive cholesteryl ester and triglyceride storage. Human Mol Genet. 1998;7:1347\u201354.","journal-title":"Human Mol Genet"},{"key":"216_CR80","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.bi.55.070186.001123","volume":"55","author":"K Figura Von","year":"1986","unstructured":"Von Figura K, Hasilik A. Lysosomal enzymes and their receptors. Annu Rev Biochem. 1986;55:167\u201393.","journal-title":"Annu Rev Biochem"},{"key":"216_CR81","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/hmg\/10.16.1639","volume":"10","author":"H Du","year":"2001","unstructured":"Du H, Schiavi S, Levine M, Mishra J, Heur M, Grabowski GA. Enzyme therapy for lysosomal acid lipase deficiency in the mouse. Human Mol Genet. 2001;10:1639\u201348.","journal-title":"Human Mol Genet"},{"key":"216_CR82","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.ATV.0000107030.22053.1e","volume":"24","author":"H Du","year":"2004","unstructured":"Du H, Schiavi S, Wan N, Levine M, Witte DP, Grabowski GA. Reduction of atherosclerotic plaques by lysosomal acid lipase supplementation. Arterioscler Thromb Vasc Biol. 2004;24:147\u201354.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"216_CR83","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1086\/498652","volume":"77","author":"H Du","year":"2005","unstructured":"Du H, Levine M, Ganesa C, Witte DP, Cole ES, Grabowski GA. The role of mannosylated enzyme and the mannose receptor in enzyme replacement therapy. Am J Hum Genet. 2005;77:1061\u201374.","journal-title":"Am J Hum Genet"},{"key":"216_CR84","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1194\/jlr.M700482-JLR200","volume":"49","author":"H Du","year":"2008","unstructured":"Du H, Cameron TL, Garger SJ, Pogue GP, Hamm LA, White E, Hanley KM, Grabowski GA. Wolman disease\/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice. J Lipid Res. 2008;49:1646\u201357.","journal-title":"J Lipid Res"},{"key":"216_CR85","doi-asserted-by":"crossref","first-page":"22479","DOI":"10.1016\/S0021-9258(18)54597-X","volume":"266","author":"RA Anderson","year":"1991","unstructured":"Anderson RA, Sando GN. Cloning and expression of cDNA encoding human lysosomal acid lipase\/cholesteryl ester hydrolase. J Biol Chem. 1991;266:22479\u201384.","journal-title":"J Biol Chem"},{"key":"216_CR86","volume-title":"SBC-102, a recombinant enzyme replacement therapy corrects key abnormalities due to lysosomal acid lipase deficiency","author":"AG Quinn","year":"2010","unstructured":"Quinn AG, Harvey A, Chen M, Christmann L, Leavitt M, Hu W. SBC-102, a recombinant enzyme replacement therapy corrects key abnormalities due to lysosomal acid lipase deficiency. Washington, DC: American Society of Human Genetics (ASHG); 2010."},{"key":"216_CR87","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/hep.26289","volume":"58","author":"M Balwani","year":"2013","unstructured":"Balwani M, Breen C, Enns GM, Deegan PB, Honzik T, Jones S, Kane JP, Malinova V, Sharma R, Stock EO, Valayannopoulos V, Wraith JE, Burg J, Eckert S, Schnieder E, Quinn AG. Clinical Effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease. Hepatol. 2013;58:950\u20137.","journal-title":"Hepatol"},{"key":"216_CR88","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.ymgme.2015.12.260","volume":"117","author":"M Friedman","year":"2016","unstructured":"Friedman M, Valayannopoulos V, Camarena CG, Sanchez AC, Kane J, Kostyleva M, Tylki-Szymanska A, Sokal E, Sharma R, Rojas-Caro S, Wolfendale N, Burton BK. Safety findings from 3 trials of treatment with sebelipase alfa in children and adults with lysosomal acid lipase deficiency. Mol Genet Metabol. 2016;117:S47.","journal-title":"Mol Genet Metabol"},{"key":"216_CR89","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/j.ymgme.2015.12.308","volume":"117","author":"SA Jones","year":"2016","unstructured":"Jones SA, Brassier A, Hughes J, Plantaz D, Vara R, Breen C, Gargus JJ, Valayannopoulos V. Effect of sebelipase alfa on survival and liver function in infants with rapidly progressive lysosomal acid lipase deficiency: 2\u00a0year follow-up data. Mol Genet Metabol. 2016;117:S63.","journal-title":"Mol Genet Metabol"},{"key":"216_CR90","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"DC Goff","year":"2014","unstructured":"Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O\u2019Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC, Sorlie P, Stone NJ, Wilson PWF. 2013 ACC\/AHA guideline on the assessment of cardiovascular risk. A report of the American College of Cardiology\/American Heart Association task force on practice guidelines. Circulation. 2014;129:S49\u201373.","journal-title":"Circulation"},{"key":"216_CR91","first-page":"704","volume":"77","author":"A Huntzinger","year":"2008","unstructured":"Huntzinger A. AHA guidelines on cardiac CT for assessing coronary artery disease. Am Fam Physician. 2008;77:704\u20136.","journal-title":"Am Fam Physician"},{"key":"216_CR92","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1542\/peds.2010-3724B","volume":"128","author":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children","year":"2011","unstructured":"Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128:S1\u201344.","journal-title":"Pediatrics"},{"key":"216_CR93","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","unstructured":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP). JAMA. 2001;285:2486\u201397.","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1007\/s40256-017-0228-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T00:00:00Z","timestamp":1490400000000}}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-017-0216-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-017-0216-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-017-0216-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T23:32:04Z","timestamp":1658619124000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-017-0216-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,14]]},"references-count":93,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["216"],"URL":"https:\/\/doi.org\/10.1007\/s40256-017-0216-5","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,14]]}}}